Firehawk Rapamycin Target Eluting Coronary Stent North American Trial
Public ClinicalTrials.gov record NCT04562532. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Multicenter Randomized Assessment of the Firehawk™ Rapamycin TARGET Eluting Cobalt Chromium Coronary Stent System - North American Trial
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The aim of the TARGET-IV NA trial is to demonstrate the clinical non-inferiority of the Firehawk® rapamycin eluting stent system in comparison to currently approved 2nd generation DES for the treatment of subjects with ischemic heart disease (NSTEMI, recent STEMI (\>24 hours from initial presentation and in whom enzyme levels have peaked), unstable angina, and stable coronary disease), with atherosclerotic target lesion(s) in coronary arteries with visually estimated reference vessel diameters ≥2.25 mm and ≤4.0 mm.
Study identification
- NCT ID
- NCT04562532
- Recruitment status
- Active, not recruiting
- Study type
- Interventional
- Phase
- Not applicable
- Enrollment
- 1,720 participants
Conditions and interventions
Conditions
Interventions
- Microport Firehawk stent Device
- 2nd generation DES (XIENCE family, Promus family, Resolute/Onyx family/Endeavor, and Orsiro stent) Device
Device
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Feb 17, 2021 (Actual)
- Primary completion
- Dec 10, 2023 (Actual)
- Completion
- Jun 30, 2027 (Estimated)
- Last update posted
- Jul 24, 2024
2021 – 2027
United States locations
- U.S. sites
- 44
- U.S. states
- 26
- U.S. cities
- 41
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Cardiology PC | Birmingham | Alabama | 35211 | — |
| Mercy Gilbert Medical Center | Gilbert | Arizona | 85297 | — |
| UC San Diego School of Medicine | La Jolla | California | 90903 | — |
| Riverside Community Hospital | Riverside | California | 92501 | — |
| Sharp Memorial Hospital | San Diego | California | 92123 | — |
| Santa Barbara Cottage Hospital | Santa Barbara | California | 93105 | — |
| Yale New Heaven Hospital | New Haven | Connecticut | 06511 | — |
| JFK Medical Center | Atlantis | Florida | 33462 | — |
| CCC Research - Countryside | Clearwater | Florida | 33756 | — |
| Clearwater Cardiovascular Consultants | Clearwater | Florida | 33756 | — |
| Memorial Hospital Jacksonville | Jacksonville | Florida | 32216 | — |
| Atlanta Veterans Affairs Medical Center | Decatur | Georgia | 30033 | — |
| Elkhart General Hospital | Elkhart | Indiana | 46514 | — |
| St. Vincent Heart Center of Indiana | Indianapolis | Indiana | 46260 | — |
| The University of Kansas Medical Center | Kansas City | Kansas | 66160 | — |
| Eastern Maine Medical Center-Northern Light Cardiology | Bangor | Maine | 04401 | — |
| Massachusetts General Hospital | Boston | Massachusetts | 02114 | — |
| Brigham and Womens Hospital | Boston | Massachusetts | 02115 | — |
| Beth Israel Deaconess Medical Center, Inc. | Boston | Massachusetts | 02215 | — |
| St. Joseph Mercy Hospital | Ann Arbor | Michigan | 13203 | — |
| McLaren Bay | Bay City | Michigan | 48708 | — |
| McLaren Greater Lansing | Lansing | Michigan | 48910 | — |
| McLaren Northern Michigan | Petoskey | Michigan | 49770 | — |
| Metropolitan Heart Vascular Institute | Coon Rapids | Minnesota | 55433 | — |
| Minneapolis Heart Institute Foundation | Minneapolis | Minnesota | 55407 | — |
| St Dominic Hospital | Jackson | Mississippi | 39216 | — |
| Boone Hospital Center | Columbia | Missouri | 65201 | — |
| Bryan Medical Center East | Lincoln | Nebraska | 68506 | — |
| Dartmouth-Hitchcock Medical Center | Lebanon | New Hampshire | 03756 | — |
| Columbia University Medical Center/NYPH | New York | New York | 10032 | — |
| St. Francis Hospital & Heart Center | Roslyn | New York | 11576 | — |
| NC Heart and Vascular Research | Raleigh | North Carolina | 27607 | — |
| Mercy Health St. Vincent Medical Center LLC | Toledo | Ohio | 43608 | — |
| Doylestown Hospital | Doylestown | Pennsylvania | 18901 | — |
| UPMC Hamot | Erie | Pennsylvania | 16550 | — |
| UPMC Harrisburg Hospital | Harrisburg | Pennsylvania | 17104 | — |
| Rhode Island Hospital | Providence | Rhode Island | 02903 | — |
| AnMed Health | Anderson | South Carolina | 29621 | — |
| Turkey Creek Medical Center | Knoxville | Tennessee | 37934 | — |
| Baylor Heart and Vascular Hospital | Dallas | Texas | 75226 | — |
| Texas Tech University Health | Lubbock | Texas | 79430 | — |
| East Texas Medical Center | Tyler | Texas | 75701 | — |
| Charleston Area Medical Center | Charleston | West Virginia | 25304 | — |
| Mayo Clinic Health System | La Crosse | Wisconsin | 54601 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 13 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT04562532, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jul 24, 2024 · Synced Oct 17, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT04562532 live on ClinicalTrials.gov.